Age-Specific Reference Ranges for Prostate-Specific ...
Age-Specific Reference Ranges for Prostate-Specific Antigen as a Marker for Prostate Cancer Hans-Joachim Luboldt*, Joachim F. Schindler, Herbert Ru¨bben
Download Age-Specific Reference Ranges for Prostate-Specific ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
Treatment Strategies of Ureteral Stones - EU-ACME
eu-acme.orgTreatment Strategies of Ureteral Stones Stefanos Papadoukakisa, Jens-Uwe Stolzenburgb, Michael C. Trussa,* a Department of Urology, Klinikum Dortmund, Dortmund, Germany b Department of Urology, University of Leipzig, Leipzig, Germany
Epidemiology, Staging, Grading, and Risk …
eu-acme.orgEpidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer Marc Colombela,*, Mark Solowayb, Hideyuki Akazac, Andreas Bo¨hled, Joan Paloue, Roger Buckleyf, Donald Lammg, Maurizio Brausih, J. Alfred Witjesi, Raj Persadj
Management of Acute and Chronic Retention in Men
eu-acme.orgManagement of Acute and Chronic Retention in Men Odunayo Kalejaiye, Mark J. Speakman* Taunton & Somerset NHS Trust, Somerset, UK 1. Introduction
Ileal Conduit as the Standard for Urinary Diversion …
eu-acme.orgIleal Conduit as the Standard for Urinary Diversion After Radical Cystectomy for Bladder Cancer Renzo Colomboa,*, Richard Nasprob aDepartment of Urology, University Vita-Salute San Raffaele, Scientific Institute H. San Raffaele, Milan, Italy
Epidemiology, Aetiology, and Pathogenesis of …
eu-acme.orgEpidemiology, Aetiology, and Pathogenesis of Renal Cell Carcinoma Chris Protzel, Matthias Maruschke, Oliver W. Hakenberg* Department of …
Renal Cell Carcinoma in Adults 40 Years Old or …
eu-acme.orgKidney Cancer Renal Cell Carcinoma in Adults 40 Years Old or Less: Young Age is an Independent Prognostic Factor for Cancer-Specific Survival Xavier Taccoena, Antoine Valeria,*, Jean-Luc Descotesb, Vincent Morinc,
Cystinuria—Diagnosis and Management - EU-ACME
eu-acme.orgCystinuria—Diagnosis and Management Chandra S. Biyania,*, Jon J. Cartledgeb aPinderfields General Hospital, Wakefield, UK bSt …
Intravesical Chemotherapy and BCG for the …
eu-acme.orgIntravesical Chemotherapy and BCG for the Treatment of Bladder Cancer: Evidence and Opinion Guillermo Urdanetaa, Eduardo Solsonab, Juan Paloua,* aDepartment of ...
Antibiotic Prophylaxis in Urologic Procedures: A ...
eu-acme.orgReview – Infections Antibiotic Prophylaxis in Urologic Procedures: A Systematic Review A.M. Jikke Bootsmaa, M. Pilar Laguna Pesa, Suzanne E. Geerlingsb, Astrid Goossensc,*
Managing Complications after Midurethral Sling …
eu-acme.orgManaging Complications after Midurethral Sling for Stress Urinary Incontinence Elisabetta Costantini*, Massimo Lazzeri, Massimo Porena Department of Medical-Surgical Specialties and Public Health, Section of Urology and Andrology, University of Perugia, Perugia, Italy
Related documents
Structures of Urinary System - MCCC
www.mccc.eduBio217 Fall 2012 Unit VIII 2 Nephron •Juxtaglomerular apparatus –Juxtaglomerular cells ( renin) –Macula densa (sense changes in Na+)
Diagnosis and Management of Prostate Cancer in …
www.prostate.org.nzDiagnosis and Management of Prostate Cancer in New Zealand Men Recommendations from the Prostate Cancer Taskforce
Interpretation of Clinical Laboratory Tests
homecaremissouri.org3 Specialized lab tests Specific disease states Specific drug therapy Implications for case management Overview Interpretation of Clinical Laboratory Tests date ...
Viadur (leuprolide acetate implant) DESCRIPTION
www.accessdata.fda.govViadur® (leuprolide acetate implant) DESCRIPTION . Viadur ® (leuprolide acetate implant) is a sterile nonbiodegradable, osmotically driven miniaturized implant designed to deliver leuprolide acetate for 12 months at a controlled
PMH CLINICAL PRACTICE GUIDELINES TEMPLATE - …
www.uhn.ca3 Last Revision Date – October 2015 1. UINTRODUCTION U Prostate cancer is the most frequently diagnosed cancer in Canadian males accounting for